Pilot Study to Test the Effectiveness of Combining Conventional and Complementary Medicine to Treat Low Back Pain
Model of Integrative Care in an Academic Health Center
2 other identifiers
interventional
60
0 countries
N/A
Brief Summary
This pilot study will determine the feasibility of enrolling participants from different populations for a larger study of low back pain (LBP) treatment. In addition, this study will assess the effectiveness of data collection instruments and procedures as well as utilize feedback from participants to refine a future study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable low-back-pain
Started Jul 2004
Typical duration for not_applicable low-back-pain
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2004
CompletedFirst Submitted
Initial submission to the registry
July 7, 2005
CompletedFirst Posted
Study publicly available on registry
July 12, 2005
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2006
CompletedDecember 11, 2009
December 1, 2009
July 7, 2005
December 10, 2009
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
LBP symptoms
Secondary Outcomes (2)
Feasibility of enrolling LBP patients from different populations
effectiveness of data collection instruments and procedures
Interventions
Eligibility Criteria
You may qualify if:
- Low back pain beginning 3 to 6 weeks prior to study entry
- Patient of Partners Occupational Health Center or Harvard Vanguard Medical Associates (HVMA)
- Able to speak and understand English
- Willing and able to comply with all study requirements
You may not qualify if:
- History of back surgery within 3 years prior to study entry
- History of vertebral fracture or dislocation
- Progressive or severe neurological symptoms such as loss of bowel or bladder control, numbness in groin or rectal area, or extreme leg weakness
- Severe inflammation of the vertebrae, stiffening of the joints and ligaments, or scoliosis
- Pacemaker or implanted defibrillator
- Underlying systemic or visceral disease which might be causing back pain
- Osteoporosis
- Cancer within 5 years prior to study entry. Participants with non-melanoma skin cancer are not excluded.
- Unexplained weight loss or recent unexplained fever
- Bleeding disorder or current use of anticoagulant medication
- Any disabling medical condition
- Major organ transplantation
- Current use of systemic corticosteroids
- Current use of immunosuppressive medications
- Current use of intravenous drugs
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David Eisenberg, PhD
Harvard Medical School (HMS and HSDM)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- NIH
Study Record Dates
First Submitted
July 7, 2005
First Posted
July 12, 2005
Study Start
July 1, 2004
Study Completion
April 1, 2006
Last Updated
December 11, 2009
Record last verified: 2009-12